INTRODUCTION
In England and Wales approximately 2.5% of the population have learning disabilities, of which 1.2 million are at the mild end of the spectrum1. While the mortality rate for people with learning disabilities is higher compared with the general population2, improved standards of care, more positive lifestyles and attitudes to treatment for serious illnesses have contributed to increased longevity. Mean life expectancy is estimated to be 74 years, 67 years and 58 years for those with mild, moderate and severe learning disabilities, respectively3. This has made the issue of age-related illnesses within this population group highly relevant.
MENTAL ILLNESS IN OLDER ADULTS WITH LEARNING DISABILITIES
Mental illness is common among adults with learning disabilities. Cooper’s epidemiological study4 comparing the prevalence rates of psychiatric disorder among older (≥65 years) and younger (20–65 years) adults with learning disabilities found significantly higher rates among the elderly cohort (68.7% compared with 47.9%). This was mainly accounted for by the higher point prevalence rates for dementia, generalized anxiety disorder and depression in the older cohort groups. While the ageing process can bring about a similar increased vulnerability to mental illness as seen in the general population, additional risk factors apply for people with learning disabilities. These include: the detrimental effect of pre-existing brain damage; co-morbid physical illnesses like epilepsy; specific psychiatric or behaviour disorders associated with genetic risk factors; low self-esteem which may be related to frequent placement breakdowns, past exploitation, neglect or abuse; and the complications of learned maladaptive behaviours such as self-injurious head injury.
Mental illness may go unrecognized due to a number of barriers in the pathways to health care. Service barriers can include the lack of specialist services or the lack of expertise in mainstream services, complex appointment systems that largely presume reading ability, and inaccessible health-care delivery. Problems with the doctor–user interface include communication difficulties, ‘power imbalance’ exacerbating the suggestibility of the person with learning disability, capacity issues and the complexities of atypical clinical presentations. Diagnostic overshadowing (assuming that any changes in behaviour or presentation are due to the learning disability, rather than a co-morbid illness) remains one of the major barriers preventing people with learning disabilities from accessing adequate health care5. User–carer barriers include pre-existing cognitive impairments making it difficult to obtain an accurate timeline of symptoms, the effects of past negative experiences of health-care delivery and the failure of carers to recognize symptoms. Older people with learning disabilities from ethnic minority groups may have particular problems accessing appropriate services6.
DEMENTIA IN OLDER ADULTS WITH LEARNING DISABILITIES
The rates of dementia in older people with learning disabilities are four times higher than in the general population7. However, these high rates cannot be attributed just to those with Down syndrome and Alzheimer’s disease. Strydom et al.’s epidemiological survey8 of dementia in older adults (aged ≥60 years) with learning disabilities, but without Down syndrome, has confirmed this. Alzheimer’s disease was found to be the most common sub-type, but the prevalence rates (8.6%) were almost three times higher than expected. While vascular dementia is the second commonest sub-type in the general population, Lewy body and frontotemporal dementias were found to be commoner in the older learning disabled population. Vascular dementia had a prevalence rate of 2.7%. Explanations for these increased prevalence rates include the effects of poorly controlled epilepsy or other physical illnesses, the detrimental effects of brain damage during birth and early life, and genetic risk factors8.
Diagnosing dementia in people with learning disabilities can be difficult due to the wide range of pre-existing baseline cognitive, functional and behavioural impairments. Individuals are more likely to present with the behavioural and psychological symptoms of dementia, or with atypical symptoms such as unexplained seizures. Greater emphasis should be placed on personality and behavioural changes, in association with functional change, as diagnostic indicators9. Diagnostic difficulties can also result from altered social or communication skills making it difficult to identify subjective symptoms (psychosocial masking/intellectual distortion), and from diagnostic overshadowing10.
Good collateral information from the person’s carers is essential. The exacerbation of pre-existing deficits (‘baseline exaggeration’) may only be detected in day-care environments, where the person has more demands placed upon them.
Table 109.1 Differential diagnoses of dementia: what are the causes of cognitive, behavioural or psychological decline in an older person with learning disability?
Causes | Examples |
Medical | Physical |
Hypothyroidism Recurrent urinary/respiratory tract infections Deteriorating epilepsy Anaemia Persistent or intermittent constipation Visual impairments (e.g. cataracts) Hearing impairments (including ear wax) Medication side effects (e.g. beta-blockers, anticonvulsants) Psychiatric Dementia Normal age-related decline Depression Anxiety-related disorders (e.g. worsening obsessive-compulsive disorder or phobias) Psychotropic medication side effects | |
Psychological | Bereavement-like response to loss events (e.g. death of a family member/carer/friend; care staff/friends moving; day centre closure) Environmental re-triggering of past traumatic events |
Social | Changes in staffing/layout/structure/routine at home/day activities, within the context of autism Physical/sexual/other abuse |
A detailed history and clinical examination, incorporating the ‘medical-psychological-social model’ can help exclude ‘pseudo-dementia’ symptoms (Table 109.1). While the clinical domains affected in Alzheimer’s disease in older adults with learning disabilities are similar to those in the general elderly population, their presentation can be different (Table 109.2).
The Mini Mental State Examination is not valid for use in people with learning disabilities, but there are a number of alternative observer-rated scales available. Examples include the Dementia Scale for Down Syndrome (DSDS), the Dementia Questionnaire for Persons with Mental Retardation (DMR), and the Modified Cambridge Examination for Mental Disorders of the Elderly informant interview11.
Medical investigations should be focused on excluding the differential diagnoses of dementia. A full blood count, B12/folate levels, ESR or CRP, urea/electrolytes, blood glucose/calcium levels, liver function/thyroid function tests and urinalysis should be done. A baseline ECG (to exclude bradycardic conduction deficits) can be helpful if anticholinesterase treatment is being considered. Neuroimaging should be used to help support a clinical diagnosis, as people with learning disabilities can have baseline frontotemporal abnormalities. Within the context of dementia, people with Down syndrome may develop more significant atrophy in the frontal and temporal lobes12, hippocampus and amygdala13.
Management should be based upon pharmacological and non-pharmacological interventions within the context of broad, multidisciplinary ‘bio-psycho-social’ approaches. Affected individuals can often be maintained in their existing environment10 with additional support or adaptations. If the person needs to be moved into residential care, significant issues arise as to the suitability of mainstream dementia homes with significantly older people6.
A number of studies have reported on the efficacy and safety of using acetylcholinesterase inhibitors (especially donepezil) in older people with learning disabilities14,15. Antidementia drug treatment can be initiated by the learning disabilities psychiatrist16

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

